Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT06190093

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06190093. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 3:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Effectiveness of ONS-5010 Compared to Lucentis® in Subjects With Neovascular Age-related Macular Degeneration; NORSE EIGHT

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multicenter, randomized, masked, controlled study of the safety and effectiveness of intravitreally administered ONS-5010.

Study identification

NCT ID
NCT06190093
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Outlook Therapeutics, Inc.
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 24, 2024 (Actual)
Primary completion
Nov 7, 2024 (Actual)
Completion
Dec 5, 2024 (Actual)
Last update posted
Jul 23, 2026

2024

United States locations

U.S. sites
61
U.S. states
23
U.S. cities
60
Facility City State ZIP Site status
Clinical Site Arcadia California 91006 —
Clinical Site Bakersfield California 93309 —
Clinical Site Beverly Hills California 90210 —
Clinical Site Huntington Beach California 92647 —
Clinical Site Laguna Hills California 92653 —
Clinical Site Long Beach California 90807 —
Clinical Site Modesto California 95356 —
Clinical Site Oakland California 94611 —
Clinical Site Pasadena California 91107 —
Clinical Site Poway California 92064 —
Clinical Site Sacramento California 95841 —
Clinical Site Colorado Springs Colorado 80909 —
Clinical Site Lakewood Colorado 80228 —
Clinical Site Waterford Connecticut 06385 —
Clinical Site Coral Springs Florida 33067 —
Clinical Site Fort Lauderdale Florida 33308 —
Clinical Site Jacksonville Florida 32216 —
Clinical Site Orlando Florida 32806 —
Clinical Site Stuart Florida 34994 —
Clinical Site Oak Forest Illinois 60452 —
Clinical Site Oak Park Illinois 03440 —
Clinical Site Carmel Indiana 46290 —
Clinical Site Lenexa Kansas 66215 —
Clinical Site Lexington Kentucky 40509 —
Clinical Site Hagerstown Maryland 21740 —
Clinical Site Edina Minnesota 55435 —
Clinical Site Saint Louis Park Minnesota 55416 —
Clinical Site Jackson Mississippi 39202 —
Clinical Site Teaneck New Jersey 07666 —
Clinical Site Albuquerque New Mexico 87109 —
Clinical Site Liverpool New York 13088 —
Clinical Site Oceanside New York 11572 —
Clinical Site Rochester New York 14620 —
Clinical Site Westbury New York 11590 —
Clinical Site Asheville North Carolina 28803 —
Clinical Site Hickory North Carolina 28602 —
Clinical Site Wake Forest North Carolina 27587 —
Clinical Site Winston-Salem North Carolina 27103 —
Clinical Site Edmond Oklahoma 73013 —
Clinical Site Charleston South Carolina 29414 —
Clinical Site Florence South Carolina 29501 —
Clinical Site Ladson South Carolina 29456 —
Clinical Site West Columbia South Carolina 29169 —
Clinical Site Rapid City South Dakota 57701 —
Clinical Site Germantown Tennessee 38138 —
Clinical Site Abilene Texas 79606 —
Clinical Site Arlington Texas 76012 —
Clinical Site Austin Texas 78705 —
Clinical Site Beaumont Texas 77707 —
Clinical Site Bellaire Texas 77401 —
Clinical Site Dallas Texas 75231 —
Clinical Site Round Rock Texas 78681 —
Clinical Site San Antonio Texas 78240 —
Clinical Site San Antonio Texas 78251 —
Clinical Site The Woodlands Texas 77384 —
Clinical Site Willow Park Texas 79606 —
Clinical Site Salt Lake City Utah 84107 —
Clinical Site Fairfax Virginia 22031 —
Clinical Site Lynchburg Virginia 24502 —
Clinical Site Bellevue Washington 98004 —
Clinical Site Silverdale Washington 98383 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06190093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2026 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.